Tag Archives: stewardship

WHAT ARE SOME EXAMPLES OF ANTIMICROBIAL STEWARDSHIP PROGRAMS IN HEALTHCARE FACILITIES

Antimicrobial stewardship refers to coordinated programs that promote the appropriate use of antimicrobials (including antibiotics), improve patient outcomes, reduce microbial resistance, and decrease the spread of infections caused by multidrug-resistant organisms. The core elements of an effective ASP include leadership commitment, accountability, drug expertise, action, tracking, reporting, and education. Various healthcare facilities have developed innovative ASP models encompassing these core elements.

Many hospitals have implemented multidisciplinary antimicrobial stewardship teams or committees that meet regularly to review antimicrobial prescribing across the facility. These teams are usually composed of infectious diseases physicians, clinical pharmacists, microbiologists, infection preventionists, and other stakeholders. They monitor antibiotic use; review culture and susceptibility data; generate regular reports on antibiotic use and resistance patterns; develop evidence-based treatment guidelines, order forms, and preauthorization processes; and provide feedback to physicians on opportunities to optimize prescribing for individual patients.

For example, Mayo Clinic in Rochester, Minnesota has a longstanding and highly successful ASP led by an infectious diseases physician and antimicrobial stewardship pharmacist. They conduct prospective audit and feedback on all patients prescribed restricted or intravenous antibiotics, issue facility-wide guidelines and clinical pathways, and perform ongoing education, surveillance and process improvement. Multidrug-resistant organism infections have decreased substantially since the program’s inception in 1995.

Some health systems have implemented ASPs across all affiliated hospitals, clinics, and long-term care facilities in a coordinated manner. For example, Intermountain Healthcare in Utah consolidated its individual hospital ASPs in 2013 into a system-wide program with standard policies, order sets, reporting, and an inter-facility information-sharing infrastructure. Joint strategies are developed that consider resistance patterns and antibiotic use across the entire delivery network.

Several ASPs have also leveraged clinical decision support within electronic health record (EHR) systems. For instance, Johns Hopkins Hospital incorporates “best practice advisories” into physician order entry to prompt reviews of ongoing therapy need, narrowing of broad-spectrum drugs, and switches to oral step-downs. Many EHRs also interface with laboratory systems to automatically suspend non-ICU antibiotics if blood or urine cultures are finalized as negative after 48-72 hours.

Some innovative ambulatory ASP strategies involve primary care clinics. For example, primary care doctors at Kaiser Permanente Northern California can request real-time infectious diseases consultation for guidance on optimal outpatient antibiotic selections. Their ASP specialists also analyze prescribing patterns across clinics and develop quality improvement initiatives accordingly, focusing both on appropriate treatment and mitigating unnecessary use.

Several long-term care facilities have ASPs tailored to their residents. For instance, an ASP was implemented across 31 nursing homes in Sweden from 2014-2018. It focused on structured implementation of diagnostic and treatment algorithms, facilities-based guidelines, environmental improvements like antimicrobial stewardship rounds and education, and local and national reporting of antimicrobial usage and resistance data. Significant reductions were observed in nursing home antibiotic use and costs over the study period.

ASPs have also been initiated in dental practices and dialysis centers, given their extensive antibiotic exposure risk. They employ strategies like prescribing criteria, local guidelines, environmental cleaning enhancements and antimicrobial mouthwashes or prophylaxis as appropriate. Regular staff education is another core ASP activity in these outpatient specialty settings.

There are many organizational models for implementing successful ASPs to improve antibiotic prescribing across healthcare systems. The most impactful programs utilize multidisciplinary teams, real-time decision support, coordinated education, and standardized surveillance to drive culture and policy changes. With leadership commitment and the engagement of prescribers, ASPs have been shown to yield meaningful reductions in antibiotic overuse and resistance across both inpatient and outpatient care settings.

WHAT ARE SOME EXAMPLES OF ANTIBIOTIC STEWARDSHIP PROGRAMS THAT HAVE BEEN SUCCESSFUL IN REDUCING RESISTANCE SELECTION PRESSURES

Some noteworthy antibiotic stewardship programs that have successfully reduced antibiotic resistance include the following:

The Duke Antimicrobial Stewardship Outreach Network (DASON) implemented collaborative antimicrobial stewardship programs across 55 North Carolina nursing homes between 2012-2017. Through educational outreach, reporting of antimicrobial use and resistance data, and recommendations for treatment guidelines, DASON was able to significantly reduce broad-spectrum antibiotic use by 32% and total antibiotic days of therapy by 19% across participating facilities. Critically, they also observed reductions in key resistance genes and multidrug-resistant organisms (MDROs) colonizing nursing home residents. This demonstrated how stewardship interventions can help curb resistance selection pressures even in vulnerable long-term care settings.

At Vanderbilt University Hospital, a multifaceted antimicrobial stewardship program was launched in 2010 focused on prospective audit and feedback, formulary restriction and preauthorization, clinical guidelines, and education. Through these interventions,broad-spectrum antibiotic use declined by 36%, total antibiotic use fell by 27%, and hospital-onset Clostridium difficile infections decreased by 56%. Overall hospital mortality also improved. Genome sequencing analysis of C. difficile isolates revealed an 8.4% annual decline in fluoroquinolone-resistant strains following program implementation, directly tying the resistance reduction to decreased selection pressure from stewardship-driven decreases in fluoroquinolone prescribing.

Brigham and Women’s Hospital in Boston initiated a successful antimicrobial stewardship program in 2006 focused on prospective audit and feedback, clinical guidelines, formulary restriction, and education. Over the subsequent decade, they achieved 25-40% reductions in use of broad-spectrum antibiotics, a 40% reduction in total antibiotic days of therapy, and significant declines in hospital-onset C. difficile,vancomycin-resistant enterococci, and multidrug-resistant Gram-negative bacilli infections. Whole genome sequencing analysis of Enterobacteriaceae isolates found reduced acquisition and transmission of antibiotic resistance genes as well as stabilizing or declining resistance trends for many resistance phenotypes. The program was directly attributed with helping to curb rising resistance rates.

A multinational point-prevalence study of 233 ICUs across 75 countries before and after implementing antibiotic stewardship found a 15% reduction in antibiotic use along with reductions in antibiotic resistance, without negatively impacting clinical outcomes. Extended-spectrum beta-lactamase (ESBL) production in E. coli isolates fell from 21% to 18% of isolates, and methicillin-resistant Staphylococcus aureus (MRSA) bacteremias decreased from 21 to 17 per 1,000 patient-days after stewardship implementation. This study demonstrated the global potential for antimicrobial stewardship to curb rising resistance.

In the Netherlands, strict guidelines and national quality indicators for judicious antibiotic prescribing, particularly of fluoroquinolones and third-generation cephalosporins, led to substantial reductions in overall antibiotic use and use of highest-priority critically important antibiotics between 2000-2015. Genome sequencing found significant concurrent declines in quinolone resistance determinants and ESBL genes matching the decreases in selecting antibiotic pressure. The Netherlands programs are considered a model of success for implementing resistance-reducing antibiotic stewardship on a national scale.

These successful antibiotic stewardship programs highlight that through coordinated multi-pronged efforts of guideline development, education, and audit-based feedback on prescribing appropriateness and compliance, significant and sustained reductions in broad-spectrum antibiotic use, total antibiotic exposure, and key antibiotic-resistant infections can be achieved. Critically, genomic evidence from several programs directly links the resulting decreases in antibiotic selection pressure to stabilization or reductions in antibiotic resistance gene acquisition and transmission. Such programs demonstrate antibiotic stewardship’s vital role in helping curb the growing global public health crisis of antibiotic resistance.